Conference on Ensuring Quality Standards in Generic Drugs

13 October, 2017, Hotel Fortune Park JP Celestial, Bangalore

About Event


India's Pharma industry has been at the forefront of the public health revolution to make medicines affordable. Generic drug manufacturers in India have lowered prices of a range of therapeutics and saved millions of lives.
But time and again various doubts have been raised about the quality of medicines manufactured in India which has not only threatened domestic production but also exports.
Quality assurance of medicines is a feature of all procedures and processes employed throughout the production chain: whether development, manufacture, monitoring, distribution or final use. Unfortunately, it is not possible to evaluate the quality of products merely through the provision of a compliance certificate for good manufacturing practices (GMP) or from the results of a quality control test. The specific criteria of quality control each confirm the validity of different stages of manufacture and process control points. Quality thus has to be built in at each critical stage of the production process, the end result of which is the production of a medicinal product fit for its purpose and use. Even the Government of India has made it mandatory for any drug to conduct bio-equivalence studies or tests in India before they are launched in the market in order to ensure generic medicines have the same quality and efficacy as their branded counterparts
To address this subject matter of national importance, ASSOCHAM in association with Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, Govt. of India is organizing a Conference on “Ensuring Quality Standards in Generic Drugs” on October 13, 2017 at Hotel Fortune Park JP Celestial, Bangalore with an aim to promote highest standards of quality in generic drug manufacturing practice. It will provide a forum for multilateral and face-to-face interaction between all the stakeholders at a common platform for reaching sustainable solutions.
Hon’ble Union Minister for Chemicals & Fertilizers, Govt. of India, Shri Ananth Kumar has given his consent to be the Chief Guest and inaugurate the conference.
Participants Profile
·         Central Govt. officials
·         State Govt. officials
·         Representatives from Pharmaceutical companies
·         Pharma manufacturing professionals
·         Pharma quality professionals
·         Pharma R&D companies
·         Pharma R&D professionals
·         Representatives from Pharma Academic Institutions
Registration Fee
Rs. 2,000 + 18% GST
For more details, please contact
Mr. Anshul Gupta, +91-7838665766,